Henry Schein, Inc. (LON:0L3C)
76.18
-1.38 (-1.77%)
Dec 24, 2025, 2:30 PM BST
Henry Schein Revenue
Henry Schein had revenue of $3.34B USD in the quarter ending September 27, 2025, with 5.20% growth. This brings the company's revenue in the last twelve months to $12.94B, up 3.51% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.94B
Revenue Growth
+3.51%
P/S Ratio
0.69
Revenue / Employee
$517.52K
Employees
25,000
Market Cap
6.65B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | 9.99B | 568.20M | 6.03% |
| Dec 29, 2018 | 9.42B | 534.17M | 6.01% |
| Mar 31, 2018 | 8.88B | - | - |
| Dec 30, 2017 | 8.88B | -2.69B | -23.23% |
| Dec 31, 2016 | 11.57B | 941.95M | 8.86% |
| Dec 26, 2015 | 10.63B | 258.33M | 2.49% |
| Dec 27, 2014 | 10.37B | 810.74M | 8.48% |
| Dec 28, 2013 | 9.56B | 620.68M | 6.94% |
| Dec 29, 2012 | 8.94B | 409.73M | 4.80% |
| Dec 31, 2011 | 8.53B | 1.00B | 13.33% |
| Dec 25, 2010 | 7.53B | 988.45M | 15.12% |
| Dec 26, 2009 | 6.54B | 157.92M | 2.48% |
| Dec 27, 2008 | 6.38B | 490.53M | 8.33% |
| Dec 29, 2007 | 5.89B | 853.95M | 16.96% |
| Dec 30, 2006 | 5.04B | 509.92M | 11.27% |
| Dec 31, 2005 | 4.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Henry Schein News
- 19 days ago - Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement - GuruFocus
- 19 days ago - Barclays Initiates Coverage on HSIC with Overweight Rating | HSIC Stock News - GuruFocus
- 23 days ago - Henry Schein Can Make Your Portfolio Smile - Seeking Alpha
- 26 days ago - Henry Schein Inc at Piper Sandler Healthcare Conference Transcript - GuruFocus
- 26 days ago - Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - HSIC Stock Benefits From Expanded Partnership With vVARDIS - Nasdaq
- 27 days ago - Henry Schein Expands Partnership with vVARDIS - Business Wire
- 27 days ago - HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch - Nasdaq